Insmed Incorporated (0JAV.L)
| Previous close | 70.86 |
| Open | 70.67 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 70.33 - 72.50 |
| 52-week range | 16.58 - 72.50 |
| Volume | |
| Avg. volume | 1,364 |
| Market cap | 6.485B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.78 |
| Earnings date | 24 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireNew Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today presented positive late-breaking subgroup data from the Phase 3 ASPEN study, a global, randomized, double-blind, placebo-controlled Phase 3 study to assess the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis. Posters with the details from th
Insider MonkeyInsmed Inc. (INSM): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at where Insmed Inc. (NASDAQ:INSM) stands against the other great performing NASDAQ stocks. Market Expectations for the Year-End Fed’s recent cut has resulted in significant outperformance in the tech sector, signaling a […]
- PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 52 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
